Le LÚzard
Classified in: Health
Subject: AWD

Los Angeles Oral and Facial Surgeon Dr. David Salehani Recognized as a 2024 Top Patient Rated Surgeon


Dr. David Salehani, a board-certified oral and maxillofacial surgeon in Los Angeles, has been recognized as a 2024 Top Patient Rated Oral and Facial Surgeon by Find Local Doctors, reflecting his exceptional patient care and comprehensive range of surgical and nonsurgical procedures.

WEST HOLLYWOOD, Calif., June 21, 2024 /PRNewswire-PRWeb/ -- Dr. DavidáSalehani, a leading board-certified oral and maxillofacial surgeon in Los Angeles, has been honored as a 2024 Top Patient Rated Oral and Facial Surgeon by Find Local Doctors. This recognition highlights Dr. Salehani's dedication to excellence in patient care, as reflected in the numerous positive reviews and high ratings he has received from his patients.

"We are honored to receive this recognition from our patients," says Dr. David Salehani. "It validates our commitment to providing exceptional oral and facial surgical care in a compassionate and supportive environment."

Conveniently located in West Hollywood, Dr. Salehani's practice, Sunset Oral and Facial Surgery, is renowned for its comprehensive range of both surgical and nonsurgical procedures. Dr. Salehani is committed to delivering the highest quality care with a personalized approach, ensuring that each patient achieves optimal results tailored to their individual needs.

Dr. Salehani's extensive training and expertise encompass a full spectrum of oral and maxillofacial procedures, including dental and facial implants, cosmetic facial procedures, facial reconstruction, facial recontouring, chin implants/genioplasty, orthognathic surgery, and treatment for TMJ disorders. His practice also offers advanced cosmetic procedures such as injectables, Radiofrequency microneedling (Morpheus8), and RF skin t treatments (FaceTite and AccuTite), making it a one-stop destination for both functional and aesthetic enhancements.

"We are honored to receive this recognition from our patients," says Dr. David Salehani. "It validates our commitment to providing exceptional oral and facial surgical care in a compassionate and supportive environment."

More About Dr. David Salehani:

Dr. David Salehani earned his undergraduate degree in Biochemistry with honors, a medical degree, and his dental degree with honors from the State University of New York at Stony Brook. He completed his Oral and Maxillofacial Surgery training at Long Island Jewish Medical Center and Stony Brook University Hospital a Level I trauma Center. Dr. Salehani further honed his skills with an internship in general surgery at Stony Brook University Hospital.

Dr. Salehani's practice is dedicated to both functional and cosmetic surgery, offering procedures that range from complicated oral surgical procedures and dental/facial implants to facial trauma surgery and corrective jaw surgery. His holistic approach ensures that patients not only achieve their desired aesthetic outcomes but also experience improved health and function.

Dr. Salehani is an active member of several prestigious organizations, including the American Association of Oral and Maxillofacial Surgeons, the California Association of Oral and Maxillofacial Surgeons, and the American Dental Association. He also holds hospital privileges at UCLA Medical Center and Long Beach Memorial Medical Center and Children's Hospital.

For more information about Dr. David Salehani or to schedule an appointment, please visit Sunset Oral and Facial Surgery: https://www.sunsetoralsurgery.com/ or call (310) 275-3635.

Media Contact

Dr. David Salehani, Sunset Oral and Facial Surgery, (310) 275-3635, [email protected], https://www.sunsetoralsurgery.com/

SOURCE Sunset Oral and Facial Surgery


These press releases may also interest you

at 05:00
A new study by scientists atádeCODE Genetics, subsidiary of Amgen, shows that sequence variants drive the correlation between DNA methylation and gene expression. The same variants are linked to various diseases as well as other human traits....

at 05:00
NuclearN, a leading innovator in the nuclear industry, is proud to highlight its platform designed by nuclear engineers for nuclear engineers to manage outage schedules. The platform enhances efficiency, compliance, and cost-effectiveness in nuclear...

at 04:35
Gilead Sciences, Inc. today announced full efficacy and safety results from its pivotal, Phase 3 PURPOSE 1 trial. Detailed data from the trial's interim analysis announced in June showed that lenacapavir, the company's twice-yearly injectable HIV-1...

at 03:09
Ricovr Healthcare is proud to announce that it has been awarded a competitive Small Business Innovation Research grant from the National Institute on Drug Abuse (NIDA) at the National Institutes of Health (NIH) for the development of its...

at 03:05
Saphetor SA, the creators of the global human genetics community VarSome, today announced European CE mark approval of the VarSome Clinical platform for the automated variant discovery, annotation, and interpretation of Next Generation Sequencing...

at 03:05
PK MED, a French biotech company, privately owned, and established in 2019 by Truffle Capital, announced it has secured a non-dilutive DeepTech financing of ? 1.5 million from Bpifrance. The funding will accelerate the company's project PKM-02, an...



News published on and distributed by: